Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
Identifieur interne : 002B48 ( PubMed/Corpus ); précédent : 002B47; suivant : 002B49Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
Auteurs : Richard Y. Kao ; Wayne H W. Tsui ; Terri S W. Lee ; Julian A. Tanner ; Rory M. Watt ; Jian-Dong Huang ; Lihong Hu ; Guanhua Chen ; Zhiwei Chen ; Linqi Zhang ; Tian He ; Kwok-Hung Chan ; Herman Tse ; Amanda P C. To ; Louisa W Y. Ng ; Bonnie C W. Wong ; Hoi-Wah Tsoi ; Dan Yang ; David D. Ho ; Kwok-Yung YuenSource :
- Chemistry & biology [ 1074-5521 ] ; 2004.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Carboxypeptidases (antagonists & inhibitors), Carboxypeptidases (metabolism), Chlorocebus aethiops, Combinatorial Chemistry Techniques, Models, Molecular, Molecular Structure, Peptidyl-Dipeptidase A, SARS Virus (drug effects), SARS Virus (growth & development), SARS Virus (metabolism), SARS Virus (physiology), Severe Acute Respiratory Syndrome (drug therapy), Vero Cells, Viral Matrix Proteins (antagonists & inhibitors), Viral Matrix Proteins (metabolism), Virus Replication (drug effects).
- MESH :
- chemical , antagonists & inhibitors : Carboxypeptidases, Viral Matrix Proteins.
- chemical , chemical synthesis : Antiviral Agents.
- chemical , chemistry : Antiviral Agents.
- chemical , metabolism : Carboxypeptidases, Viral Matrix Proteins.
- chemical , pharmacology : Antiviral Agents.
- drug effects : SARS Virus, Virus Replication.
- drug therapy : Severe Acute Respiratory Syndrome.
- growth & development : SARS Virus.
- metabolism : SARS Virus.
- physiology : SARS Virus.
- Animals, Chlorocebus aethiops, Combinatorial Chemistry Techniques, Models, Molecular, Molecular Structure, Peptidyl-Dipeptidase A, Vero Cells.
Abstract
The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infected more than 8,000 people across 29 countries and caused more than 900 fatalities. Based on the concept of chemical genetics, we screened 50,240 structurally diverse small molecules from which we identified 104 compounds with anti-SARS-CoV activity. Of these 104 compounds, 2 target the SARS-CoV main protease (M(pro)), 7 target helicase (Hel), and 18 target spike (S) protein-angiotensin-converting enzyme 2 (ACE2)-mediated viral entry. The EC(50) of the majority of the 104 compounds determined by SARS-CoV plaque reduction assay were found to be at low micromolar range. Three selected compounds, MP576, HE602, and VE607, validated to be inhibitors of SARS-CoV M(pro), Hel, and viral entry, respectively, exhibited potent antiviral activity (EC(50) < 10 microM) and comparable inhibitory activities in target-specific in vitro assays.
DOI: 10.1016/j.chembiol.2004.07.013
PubMed: 15380189
Links to Exploration step
pubmed:15380189Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.</title>
<author><name sortKey="Kao, Richard Y" sort="Kao, Richard Y" uniqKey="Kao R" first="Richard Y" last="Kao">Richard Y. Kao</name>
<affiliation><nlm:affiliation>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. ryykao@hkucc.hku.hk</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tsui, Wayne H W" sort="Tsui, Wayne H W" uniqKey="Tsui W" first="Wayne H W" last="Tsui">Wayne H W. Tsui</name>
</author>
<author><name sortKey="Lee, Terri S W" sort="Lee, Terri S W" uniqKey="Lee T" first="Terri S W" last="Lee">Terri S W. Lee</name>
</author>
<author><name sortKey="Tanner, Julian A" sort="Tanner, Julian A" uniqKey="Tanner J" first="Julian A" last="Tanner">Julian A. Tanner</name>
</author>
<author><name sortKey="Watt, Rory M" sort="Watt, Rory M" uniqKey="Watt R" first="Rory M" last="Watt">Rory M. Watt</name>
</author>
<author><name sortKey="Huang, Jian Dong" sort="Huang, Jian Dong" uniqKey="Huang J" first="Jian-Dong" last="Huang">Jian-Dong Huang</name>
</author>
<author><name sortKey="Hu, Lihong" sort="Hu, Lihong" uniqKey="Hu L" first="Lihong" last="Hu">Lihong Hu</name>
</author>
<author><name sortKey="Chen, Guanhua" sort="Chen, Guanhua" uniqKey="Chen G" first="Guanhua" last="Chen">Guanhua Chen</name>
</author>
<author><name sortKey="Chen, Zhiwei" sort="Chen, Zhiwei" uniqKey="Chen Z" first="Zhiwei" last="Chen">Zhiwei Chen</name>
</author>
<author><name sortKey="Zhang, Linqi" sort="Zhang, Linqi" uniqKey="Zhang L" first="Linqi" last="Zhang">Linqi Zhang</name>
</author>
<author><name sortKey="He, Tian" sort="He, Tian" uniqKey="He T" first="Tian" last="He">Tian He</name>
</author>
<author><name sortKey="Chan, Kwok Hung" sort="Chan, Kwok Hung" uniqKey="Chan K" first="Kwok-Hung" last="Chan">Kwok-Hung Chan</name>
</author>
<author><name sortKey="Tse, Herman" sort="Tse, Herman" uniqKey="Tse H" first="Herman" last="Tse">Herman Tse</name>
</author>
<author><name sortKey="To, Amanda P C" sort="To, Amanda P C" uniqKey="To A" first="Amanda P C" last="To">Amanda P C. To</name>
</author>
<author><name sortKey="Ng, Louisa W Y" sort="Ng, Louisa W Y" uniqKey="Ng L" first="Louisa W Y" last="Ng">Louisa W Y. Ng</name>
</author>
<author><name sortKey="Wong, Bonnie C W" sort="Wong, Bonnie C W" uniqKey="Wong B" first="Bonnie C W" last="Wong">Bonnie C W. Wong</name>
</author>
<author><name sortKey="Tsoi, Hoi Wah" sort="Tsoi, Hoi Wah" uniqKey="Tsoi H" first="Hoi-Wah" last="Tsoi">Hoi-Wah Tsoi</name>
</author>
<author><name sortKey="Yang, Dan" sort="Yang, Dan" uniqKey="Yang D" first="Dan" last="Yang">Dan Yang</name>
</author>
<author><name sortKey="Ho, David D" sort="Ho, David D" uniqKey="Ho D" first="David D" last="Ho">David D. Ho</name>
</author>
<author><name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15380189</idno>
<idno type="pmid">15380189</idno>
<idno type="doi">10.1016/j.chembiol.2004.07.013</idno>
<idno type="wicri:Area/PubMed/Corpus">002B48</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.</title>
<author><name sortKey="Kao, Richard Y" sort="Kao, Richard Y" uniqKey="Kao R" first="Richard Y" last="Kao">Richard Y. Kao</name>
<affiliation><nlm:affiliation>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. ryykao@hkucc.hku.hk</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tsui, Wayne H W" sort="Tsui, Wayne H W" uniqKey="Tsui W" first="Wayne H W" last="Tsui">Wayne H W. Tsui</name>
</author>
<author><name sortKey="Lee, Terri S W" sort="Lee, Terri S W" uniqKey="Lee T" first="Terri S W" last="Lee">Terri S W. Lee</name>
</author>
<author><name sortKey="Tanner, Julian A" sort="Tanner, Julian A" uniqKey="Tanner J" first="Julian A" last="Tanner">Julian A. Tanner</name>
</author>
<author><name sortKey="Watt, Rory M" sort="Watt, Rory M" uniqKey="Watt R" first="Rory M" last="Watt">Rory M. Watt</name>
</author>
<author><name sortKey="Huang, Jian Dong" sort="Huang, Jian Dong" uniqKey="Huang J" first="Jian-Dong" last="Huang">Jian-Dong Huang</name>
</author>
<author><name sortKey="Hu, Lihong" sort="Hu, Lihong" uniqKey="Hu L" first="Lihong" last="Hu">Lihong Hu</name>
</author>
<author><name sortKey="Chen, Guanhua" sort="Chen, Guanhua" uniqKey="Chen G" first="Guanhua" last="Chen">Guanhua Chen</name>
</author>
<author><name sortKey="Chen, Zhiwei" sort="Chen, Zhiwei" uniqKey="Chen Z" first="Zhiwei" last="Chen">Zhiwei Chen</name>
</author>
<author><name sortKey="Zhang, Linqi" sort="Zhang, Linqi" uniqKey="Zhang L" first="Linqi" last="Zhang">Linqi Zhang</name>
</author>
<author><name sortKey="He, Tian" sort="He, Tian" uniqKey="He T" first="Tian" last="He">Tian He</name>
</author>
<author><name sortKey="Chan, Kwok Hung" sort="Chan, Kwok Hung" uniqKey="Chan K" first="Kwok-Hung" last="Chan">Kwok-Hung Chan</name>
</author>
<author><name sortKey="Tse, Herman" sort="Tse, Herman" uniqKey="Tse H" first="Herman" last="Tse">Herman Tse</name>
</author>
<author><name sortKey="To, Amanda P C" sort="To, Amanda P C" uniqKey="To A" first="Amanda P C" last="To">Amanda P C. To</name>
</author>
<author><name sortKey="Ng, Louisa W Y" sort="Ng, Louisa W Y" uniqKey="Ng L" first="Louisa W Y" last="Ng">Louisa W Y. Ng</name>
</author>
<author><name sortKey="Wong, Bonnie C W" sort="Wong, Bonnie C W" uniqKey="Wong B" first="Bonnie C W" last="Wong">Bonnie C W. Wong</name>
</author>
<author><name sortKey="Tsoi, Hoi Wah" sort="Tsoi, Hoi Wah" uniqKey="Tsoi H" first="Hoi-Wah" last="Tsoi">Hoi-Wah Tsoi</name>
</author>
<author><name sortKey="Yang, Dan" sort="Yang, Dan" uniqKey="Yang D" first="Dan" last="Yang">Dan Yang</name>
</author>
<author><name sortKey="Ho, David D" sort="Ho, David D" uniqKey="Ho D" first="David D" last="Ho">David D. Ho</name>
</author>
<author><name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
</analytic>
<series><title level="j">Chemistry & biology</title>
<idno type="ISSN">1074-5521</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Carboxypeptidases (antagonists & inhibitors)</term>
<term>Carboxypeptidases (metabolism)</term>
<term>Chlorocebus aethiops</term>
<term>Combinatorial Chemistry Techniques</term>
<term>Models, Molecular</term>
<term>Molecular Structure</term>
<term>Peptidyl-Dipeptidase A</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (growth & development)</term>
<term>SARS Virus (metabolism)</term>
<term>SARS Virus (physiology)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Vero Cells</term>
<term>Viral Matrix Proteins (antagonists & inhibitors)</term>
<term>Viral Matrix Proteins (metabolism)</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Carboxypeptidases</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Carboxypeptidases</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Combinatorial Chemistry Techniques</term>
<term>Models, Molecular</term>
<term>Molecular Structure</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Vero Cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infected more than 8,000 people across 29 countries and caused more than 900 fatalities. Based on the concept of chemical genetics, we screened 50,240 structurally diverse small molecules from which we identified 104 compounds with anti-SARS-CoV activity. Of these 104 compounds, 2 target the SARS-CoV main protease (M(pro)), 7 target helicase (Hel), and 18 target spike (S) protein-angiotensin-converting enzyme 2 (ACE2)-mediated viral entry. The EC(50) of the majority of the 104 compounds determined by SARS-CoV plaque reduction assay were found to be at low micromolar range. Three selected compounds, MP576, HE602, and VE607, validated to be inhibitors of SARS-CoV M(pro), Hel, and viral entry, respectively, exhibited potent antiviral activity (EC(50) < 10 microM) and comparable inhibitory activities in target-specific in vitro assays.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15380189</PMID>
<DateCompleted><Year>2005</Year>
<Month>03</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1074-5521</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>9</Issue>
<PubDate><Year>2004</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Chemistry & biology</Title>
<ISOAbbreviation>Chem. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.</ArticleTitle>
<Pagination><MedlinePgn>1293-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infected more than 8,000 people across 29 countries and caused more than 900 fatalities. Based on the concept of chemical genetics, we screened 50,240 structurally diverse small molecules from which we identified 104 compounds with anti-SARS-CoV activity. Of these 104 compounds, 2 target the SARS-CoV main protease (M(pro)), 7 target helicase (Hel), and 18 target spike (S) protein-angiotensin-converting enzyme 2 (ACE2)-mediated viral entry. The EC(50) of the majority of the 104 compounds determined by SARS-CoV plaque reduction assay were found to be at low micromolar range. Three selected compounds, MP576, HE602, and VE607, validated to be inhibitors of SARS-CoV M(pro), Hel, and viral entry, respectively, exhibited potent antiviral activity (EC(50) < 10 microM) and comparable inhibitory activities in target-specific in vitro assays.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kao</LastName>
<ForeName>Richard Y</ForeName>
<Initials>RY</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. ryykao@hkucc.hku.hk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tsui</LastName>
<ForeName>Wayne H W</ForeName>
<Initials>WH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Terri S W</ForeName>
<Initials>TS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tanner</LastName>
<ForeName>Julian A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Watt</LastName>
<ForeName>Rory M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Jian-Dong</ForeName>
<Initials>JD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Lihong</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Guanhua</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Zhiwei</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Linqi</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>He</LastName>
<ForeName>Tian</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>Kwok-Hung</ForeName>
<Initials>KH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tse</LastName>
<ForeName>Herman</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>To</LastName>
<ForeName>Amanda P C</ForeName>
<Initials>AP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ng</LastName>
<ForeName>Louisa W Y</ForeName>
<Initials>LW</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Bonnie C W</ForeName>
<Initials>BC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsoi</LastName>
<ForeName>Hoi-Wah</ForeName>
<Initials>HW</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Dan</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ho</LastName>
<ForeName>David D</ForeName>
<Initials>DD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yuen</LastName>
<ForeName>Kwok-Yung</ForeName>
<Initials>KY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Chem Biol</MedlineTA>
<NlmUniqueID>9500160</NlmUniqueID>
<ISSNLinking>1074-5521</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance UI="D002268">Carboxypeptidases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002268" MajorTopicYN="N">Carboxypeptidases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020650" MajorTopicYN="N">Combinatorial Chemistry Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>06</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2004</Year>
<Month>07</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2004</Year>
<Month>07</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>3</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15380189</ArticleId>
<ArticleId IdType="doi">10.1016/j.chembiol.2004.07.013</ArticleId>
<ArticleId IdType="pii">S1074552104002273</ArticleId>
<ArticleId IdType="pmc">PMC7128553</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Med. 2002 Apr;8(4):386-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11927945</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12965-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11087852</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Apr 11;416(6881):653-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11948353</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-2315</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12917450</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2003 Oct 10;278(41):39578-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12917423</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Dec;84(Pt 12):3291-3303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645910</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Protein Expr Purif. 2002 Feb;24(1):131-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11812234</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10066-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12118120</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1999 Oct 29;286(5441):971-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10542155</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Biol. 1994 Sep;1(1):3-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9383364</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 1998 Aug;6(8):1127-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9784856</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Genet. 2000 Nov;1(2):116-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11253651</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2003 Nov 20;554(3):257-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14623076</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14569023</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2003 Nov;71(3):323-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12966536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2002 Apr;8(4):392-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11927946</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Exp Biol Med (Maywood). 2003 Jul;228(7):866-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12876307</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002B48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:15380189 |texte= Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15380189" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |